PT  - JOURNAL ARTICLE
AU  - Alshehri, Faez Falah
TI  - Understanding the prevalence, progression, and management of metabolic syndrome in Saudi Arabia
AID  - 10.15537/smj.2023.44.10.20230450
DP  - 2023 Oct 01
TA  - Saudi Medical Journal
PG  - 973--986
VI  - 44
IP  - 10
4099  - http://smj.org.sa/content/44/10/973.short
4100  - http://smj.org.sa/content/44/10/973.full
SO  - Saudi Med J2023 Oct 01; 44
AB  - Metabolic syndrome (MetS) is characterized by the coexistence of several disorders comprising hypertension, abdominal obesity, insulin sensitivity, and dyslipidemia. In recent times, MetS has gained increased attention due to the global prevalence of obesity. Adipose tissue plays a crucial role in this syndrome by releasing various molecules significantly affecting lipid/insulin regulation, oxidative stress, and cardiovascular function. Tumor necrosis factor-α (p-α), an inflammatory cytokine, and adiponectin, an adipose tissue-specific protein, are considered vital adipokines that play a significant role in the pathogenesis of MetS. The impact of dietary ingredients on MetS management has been extensively studied over the past few decades. These plant-derived natural chemicals have demonstrated beneficial impacts on obesity, diabetes, and cardiovascular disease (CVD) due to their diverse properties. Saudi Arabia has a high prevalence of overweight and diabetes, but there has been limited research on the incidence of MetS in the country. As a result, in this review, we evaluated the prevalence of MetS in Saudi Arabia and its associated risk factors, as well as explored the mechanisms of progression of MetS and the role of natural phytochemicals in the prevention of MetS.